Postnatal Phencyclidine-Induced Deficits in Decision Making Are Ameliorated by Optogenetic Inhibition of Ventromedial Orbitofrontal Cortical Glutamate Neurons.

Learning rate Optogenetics Postnatal PCP Probabilistic reversal learning Schizophrenia vmOFC

Journal

Biological psychiatry global open science
ISSN: 2667-1743
Titre abrégé: Biol Psychiatry Glob Open Sci
Pays: United States
ID NLM: 9918227369306676

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 12 04 2023
revised: 12 07 2023
accepted: 01 08 2023
medline: 1 2 2024
pubmed: 1 2 2024
entrez: 1 2 2024
Statut: epublish

Résumé

The orbitofrontal cortex (OFC) is essential for decision making, and functional disruptions within the OFC are evident in schizophrenia. Postnatal phencyclidine (PCP) administration in rats is a neurodevelopmental manipulation that induces schizophrenia-relevant cognitive impairments. We aimed to determine whether manipulating OFC glutamate cell activity could ameliorate postnatal PCP-induced deficits in decision making. Male and female Wistar rats ( Compared with saline-treated rats expressing YFP, PCP-treated rats expressing YFP completed fewer reversals, made fewer win-stay responses, and had lower learning rates. We induced similar performance impairments in saline-treated rats by activating vmOFC glutamate cells (ChR2). Strikingly, PCP-induced performance deficits were ameliorated when the activity of vmOFC glutamate cells was inhibited (halorhodopsin). Postnatal PCP-induced deficits in decision making are associated with hyperactivity of vmOFC glutamate cells. Thus, normalizing vmOFC activity may represent a potential therapeutic target for decision-making deficits in patients with schizophrenia.

Sections du résumé

Background UNASSIGNED
The orbitofrontal cortex (OFC) is essential for decision making, and functional disruptions within the OFC are evident in schizophrenia. Postnatal phencyclidine (PCP) administration in rats is a neurodevelopmental manipulation that induces schizophrenia-relevant cognitive impairments. We aimed to determine whether manipulating OFC glutamate cell activity could ameliorate postnatal PCP-induced deficits in decision making.
Methods UNASSIGNED
Male and female Wistar rats (
Results UNASSIGNED
Compared with saline-treated rats expressing YFP, PCP-treated rats expressing YFP completed fewer reversals, made fewer win-stay responses, and had lower learning rates. We induced similar performance impairments in saline-treated rats by activating vmOFC glutamate cells (ChR2). Strikingly, PCP-induced performance deficits were ameliorated when the activity of vmOFC glutamate cells was inhibited (halorhodopsin).
Conclusions UNASSIGNED
Postnatal PCP-induced deficits in decision making are associated with hyperactivity of vmOFC glutamate cells. Thus, normalizing vmOFC activity may represent a potential therapeutic target for decision-making deficits in patients with schizophrenia.

Identifiants

pubmed: 38298783
doi: 10.1016/j.bpsgos.2023.08.002
pii: S2667-1743(23)00091-5
pmc: PMC10829674
doi:

Types de publication

Journal Article

Langues

eng

Pagination

264-274

Informations de copyright

© 2023 The Authors.

Auteurs

Michael M Tranter (MM)

Department of Psychiatry, University of California San Diego, La Jolla, California.
Research Service, VA San Diego Healthcare System, La Jolla, California.

Lauren Faget (L)

Department of Neurosciences, University of California San Diego, La Jolla, California.

Thomas S Hnasko (TS)

Research Service, VA San Diego Healthcare System, La Jolla, California.
Department of Neurosciences, University of California San Diego, La Jolla, California.

Susan B Powell (SB)

Department of Psychiatry, University of California San Diego, La Jolla, California.
Research Service, VA San Diego Healthcare System, La Jolla, California.

Daniel G Dillon (DG)

Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Samuel A Barnes (SA)

Department of Psychiatry, University of California San Diego, La Jolla, California.
Research Service, VA San Diego Healthcare System, La Jolla, California.

Classifications MeSH